$PSBD

Palmer Square Capital BDC Inc. (PSBD): Entry into a Material Definitive Agreement

Palmer Square Capital BDC Inc. (PSBD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.3 2 ea029807301ex10-3.htm NOTE PURCHASE AGREEMENT, DATED AS OF JULY 15, 2026, BY AND AMONG PALMER SQUARE BDC CLO 1, LTD., AS ISSUER, PALMER SQUARE BDC CLO 1, LLC, AS CO-ISSUER, AND BOFA SECURITIES, INC., AS INITIAL PURCHASER Exhibit 10.3 EXECUTION VERSION REFINANCING NOTE P

Original reporting
Published Jul 15, 2026, 8:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 15, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$PSBD
Neutral
medium confidence
Mentioned
$PSBD
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PSBDNeutralMed
01

Why it matters

A refinancing transaction can change PSBD’s underlying CLO funding profile and therefore its risk-adjusted earnings and NAV sensitivity, but the excerpt does not provide the economic terms.

02

Market read

This is a new, same-day refinancing agreement disclosure that may affect PSBD’s structured credit funding risk, but the excerpt lacks pricing details.

03

What to watch

Traders should look for the final offering circular and any subsequent 8-K amendments that disclose spreads, ratings, and whether the refinancing reduces or extends duration and leverage.

Relevance 6/10Novelty 6/10Timing: Filed July 15, 2026, covering a refinancing note purchase agreement closing on the same date.

Background

The filing is an SEC Form 8-K Item 1.01 describing entry into a material definitive agreement, specifically a refinancing note purchase agreement dated July 15, 2026.

Company-level read

Ticker impact

$PSBDNeutralMedium confidence
Context

PSBD entered a material definitive agreement for a July 15, 2026 refinancing note purchase, with BofA Securities as initial purchaser.

Expected impact

Likely modest, with direction depending on the refinancing terms (not provided in the excerpt).

Evidence & confidence

This is a primary SEC filing indicating a new financing/refinancing transaction, but the excerpt does not include coupon, spread, principal amounts, or maturity details needed to forecast magnitude or direction.

Market effects

BDC/CLO funding activity can signal relative credit-market liquidity and refinancing conditions for structured credit vehicles.

Primarily US structured credit and capital markets sentiment.

Limited, unless the refinancing reflects broader stress or liquidity shifts in global credit markets.

Counterpoint

Without the actual note terms (pricing, size, maturity, call features), the filing may be largely administrative and not a meaningful driver of PSBD equity risk.

Key entities

  • Palmer Square Capital BDC Inc.

    Subject of the 8-K, associated with the refinancing note purchase agreement for Palmer Square BDC CLO 1 vehicles.

  • Palmer Square BDC CLO 1, Ltd.

    Cayman exempted company, named as issuer in the note purchase agreement.

  • Palmer Square BDC CLO 1, LLC

    Delaware LLC, named as co-issuer in the note purchase agreement.

  • BofA Securities, Inc.

    Refinancing initial purchaser and lead manager in the agreement.

Related articles

$PSBDMed

Palmer Square Capital BDC Q2 Earnings Call Highlights

Palmer Square Capital BDC (PSBD) reported Q2 NAV per share of $13.21, down from $13.30, citing fair-value adjustments tied to broadly syndicated loan pricing. Portfolio fair value was about $1.11B. It made 21 commitments totaling $72.4M and realized $109.8M from repayments and sales. Management expanded buybacks and reset a BDC CLO to lower debt cost.

$PSBDMed

Palmer Square Capital BDC Inc. (PSBD): Results of Operations and Financial Condition

Palmer Square Capital BDC Inc. (PSBD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Palmer Square Capital BDC Inc. Announces Second Quarter 2026 Financial Results Declares Third Quarter 2026 Base Dividend of $0.36 Per Share with Supplemental Dividend Expected to be Announced in September MISSION WOODS, Kansas, August 5, 2026 — Palmer Square Capital

$HALOMedAI 9/10

Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033

Halozyme Therapeutics (HALO) priced a $1.3B upsized offering of 1.50% convertible senior notes due 2033, with a 13-day option for additional $200M. Notes have an initial conversion price of $139.84, a 27.5% premium over the closing price. Proceeds (~$1.275B) will fund capped call transactions, repurchase existing notes, and general corporate purposes. The company expects to close the offering on September 22, 2026.

$CTVAMed

Corteva Fires Back as States Move to Block Corporate Split on Oct. 1

Corteva is defending its planned split into two companies, Corteva and Vylor, against a legal challenge from 21 states. The states argue the split could hinder PFAS liability claims, but Corteva denies wrongdoing and asserts the separation is strategic. Corteva plans to keep its headquarters in Indianapolis, while Vylor will be based in Iowa. The court will decide if the split can proceed as scheduled on Oct. 1.

HighAI 9/10

CoreWeave $3B Convertible Debt Plan

CoreWeave plans a $3B convertible debt sale, with an option for an additional $500M. The company also authorized an at-the-market share sale of up to 35M shares. Proceeds will fund AI compute infrastructure and offset dilution. In Q3, CoreWeave signed deals for compute capacity at an annualized rate of $40M per megawatt, increasing its contracted power capacity to 4.2 gigawatts.